Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21701,193,1.65 [1.15-2.38],0.007080358991434
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22912,247,1.82 [1.32-2.51],0.0002777840033266
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22641,1757,1.54 [1.36-1.74],2.01508235166136e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,22918,544,1.55 [1.23-1.94],0.0001664254870414
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22169,4217,1.37 [1.26-1.49],8.675165611189218e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22105,4293,1.50 [1.38-1.63],5.003881597022756e-22
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22630,1428,1.44 [1.25-1.66],3.6722383131258804e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22823,129,1.94 [1.25-3.01],0.0031381386539328
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20098,1296,1.93 [1.66-2.23],1.3925508622186621e-18
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19401,1582,1.92 [1.68-2.19],8.15697248138678e-22
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18894,341,2.35 [1.80-3.08],3.367208166114999e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14916,2742,1.52 [1.37-1.69],1.4784388546734917e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18832,497,2.03 [1.61-2.56],1.965135064262099e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22895,1693,1.43 [1.26-1.63],6.472962290719774e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23012,638,1.50 [1.22-1.85],0.0001553895541963
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22129,1245,1.57 [1.35-1.82],3.8072033203930114e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22937,1429,1.73 [1.51-1.98],1.7139329777209302e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21449,247,1.84 [1.34-2.53],0.000173542643127
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23071,67,1.54 [0.81-2.95],0.1878779679805394
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22757,1249,1.79 [1.55-2.07],1.6341111586772552e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22772,78,1.05 [0.56-1.96],0.8798551711118513
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23007,141,1.46 [0.93-2.29],0.0958050120993297
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22984,118,1.13 [0.68-1.87],0.641176939717228
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21386,502,2.17 [1.76-2.66],1.5039133356118316e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21194,310,1.43 [1.06-1.93],0.0204793720858905
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21339,137,1.71 [1.10-2.65],0.0175077948187475
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23056,52,3.08 [1.78-5.33],5.7193426677058166e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23004,171,1.04 [0.68-1.58],0.8714275136796847
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral warts,22888,55,0.73 [0.34-1.56],0.412066392072781
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22909,76,1.44 [0.78-2.64],0.2407063634497621
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm,22776,265,1.00 [0.71-1.41],0.9782550024649748
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22987,39,0.72 [0.29-1.79],0.4820393589585291
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22971,44,0.97 [0.42-2.24],0.943460420467643
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10988,86,1.09 [0.60-1.98],0.7791628743510013
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22607,1673,1.03 [0.90-1.18],0.6666865977195436
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of meninges,23055,66,1.87 [1.00-3.50],0.0508730080475423
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22978,78,1.65 [0.92-2.98],0.0945787113938354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23043,116,1.43 [0.87-2.36],0.1550071716065761
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of ovary,12012,79,0.75 [0.39-1.42],0.3721661254798289
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23031,439,0.94 [0.72-1.23],0.6747606311102515
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23036,384,1.05 [0.79-1.40],0.7154240601846134
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22923,86,1.09 [0.60-1.97],0.7784462916199644
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23027,252,0.85 [0.59-1.20],0.3499950464633098
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Rectum,22985,410,1.12 [0.85-1.48],0.408062125485188
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22920,684,1.08 [0.87-1.33],0.4787422268823806
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23012,541,1.05 [0.83-1.33],0.7046322123664454
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Carcinoma in situ of breast,9033,51,1.18 [0.53-2.64],0.683051739943958
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9076,67,0.87 [0.43-1.76],0.7039122627473615
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16459,71,1.75 [0.93-3.30],0.0805985500419995
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16487,99,1.44 [0.83-2.50],0.1966368707997791
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23014,125,1.61 [1.00-2.58],0.0489282202440674
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma, any site",23015,122,1.61 [1.00-2.59],0.051076284022582
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Leiomyoma of uterus,11744,167,0.97 [0.63-1.50],0.8931657438836145
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lung cancer and mesothelioma,14596,478,1.07 [0.83-1.39],0.6040224372085685
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lymphoid leukaemia,16461,73,2.21 [1.22-4.01],0.0088995731385772
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16608,220,1.53 [1.06-2.21],0.0234181723837644
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16705,317,1.27 [0.93-1.73],0.1252984315737233
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9153,102,1.14 [0.65-2.00],0.6501296866434096
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16497,109,1.16 [0.68-1.97],0.580214330235425
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16532,144,1.21 [0.76-1.93],0.4158677074784531
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16511,123,1.07 [0.65-1.78],0.7806023565193015
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9137,86,0.71 [0.38-1.32],0.274872817185175
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16514,126,1.26 [0.77-2.06],0.360061157182569
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8322,985,1.03 [0.87-1.24],0.7134128927619419
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16525,137,0.92 [0.57-1.50],0.7446958800107426
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16480,92,1.10 [0.61-1.96],0.7568852136901224
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16535,147,1.07 [0.67-1.71],0.7786439909714533
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi,22925,183,1.02 [0.67-1.54],0.9328460775616738
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23043,77,1.03 [0.54-1.94],0.9350526593418294
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanoma in situ,16439,110,1.32 [0.77-2.26],0.3131514810952671
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16509,121,1.83 [1.14-2.94],0.0128878593667511
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16586,198,1.87 [1.29-2.71],0.0009792234260957
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16713,325,0.90 [0.65-1.23],0.4917557309097869
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16514,126,2.11 [1.34-3.30],0.0011421005484226
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Other benign neoplasms of skin,22899,163,1.20 [0.78-1.84],0.4145375592795729
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17868,1480,1.05 [0.91-1.22],0.5126515369022293
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17948,1560,1.05 [0.91-1.22],0.4771442021156437
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22763,394,1.75 [1.35-2.26],2.6094948388946245e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20745,167,3.42 [2.63-4.45],4.616253845696377e-20
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22439,70,2.47 [1.46-4.18],0.0007688256601902
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22301,3496,1.58 [1.44-1.73],2.3990858657369146e-23
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21357,74,1.38 [0.73-2.59],0.3166595002428005
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22595,62,2.99 [1.81-4.94],1.884299206944176e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22550,1972,1.60 [1.42-1.80],7.232503355101773e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22548,1970,1.60 [1.42-1.80],7.710925633498142e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20693,115,2.28 [1.49-3.50],0.0001623632831177
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22706,1423,1.80 [1.57-2.06],1.2864938206851549e-17
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22647,114,1.67 [1.03-2.72],0.0386424144484544
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22442,73,1.48 [0.79-2.74],0.2176288415620554
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22446,77,0.83 [0.44-1.58],0.5798453129758699
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22888,355,2.32 [1.82-2.96],1.1273470542733009e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22944,40,2.40 [1.21-4.79],0.0126375772794237
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22825,292,2.42 [1.86-3.14],4.269320161602384e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21419,136,1.40 [0.88-2.22],0.1548535598028085
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15413,416,2.26 [1.76-2.89],1.2836991564518428e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21574,105,0.65 [0.37-1.12],0.1226693829209612
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21581,112,0.60 [0.35-1.03],0.0656981212505872
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15067,70,1.12 [0.57-2.21],0.7487398232051431
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21426,65,1.32 [0.67-2.58],0.4193500038129844
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20650,319,1.43 [1.05-1.94],0.022793170043666
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22279,964,1.60 [1.35-1.90],5.731668330443789e-08
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21798,483,1.39 [1.08-1.79],0.0099635591794216
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21529,214,1.15 [0.79-1.68],0.467490414641675
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22784,1423,1.34 [1.16-1.55],7.158831623676658e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19408,1378,1.32 [1.14-1.53],0.0001837318452847
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15088,91,2.15 [1.26-3.64],0.0047420407255171
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20779,101,1.27 [0.74-2.19],0.3858170433915677
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15367,370,1.52 [1.14-2.02],0.0039726870522993
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15051,54,2.19 [1.10-4.35],0.0251992903859354
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19586,4589,1.06 [0.98-1.16],0.1462122904847179
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15263,266,1.65 [1.19-2.30],0.0029179949136534
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15708,711,1.38 [1.12-1.70],0.0023258858886827
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23011,370,1.35 [1.02-1.79],0.0338203634689426
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22801,160,1.94 [1.31-2.88],0.0009112650533762
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15150,153,0.99 [0.63-1.58],0.9813785410323596
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15079,82,2.30 [1.33-3.96],0.0027072619323695
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22431,1753,1.52 [1.34-1.73],9.948254995871022e-11
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15386,389,2.71 [2.13-3.44],2.5807454729733176e-16
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15427,430,2.94 [2.36-3.65],3.2260430163599413e-22
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15861,864,1.15 [0.95-1.39],0.1627036420600755
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15174,177,2.22 [1.52-3.26],4.3979302766311256e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22791,150,1.93 [1.28-2.90],0.0015425918763531
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15898,901,1.54 [1.28-1.84],4.212220340445704e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15657,660,1.52 [1.23-1.88],0.0001202432327139
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20409,78,1.77 [0.98-3.22],0.0597017593698107
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21421,6424,1.15 [1.07-1.23],0.0001164947564248
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20737,59,2.04 [1.08-3.85],0.0281935150467122
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20729,51,2.63 [1.43-4.83],0.0018215930859893
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22885,1900,1.02 [0.90-1.16],0.7399250147427223
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22884,1899,1.02 [0.90-1.16],0.7688941345951761
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20742,64,2.16 [1.20-3.87],0.0097142928900353
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22715,1129,1.05 [0.89-1.23],0.6016211127516299
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17246,2249,1.68 [1.50-1.89],2.571730008341519e-19
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23055,317,3.17 [2.60-3.85],2.3187522203764457e-30
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21446,131,1.50 [0.94-2.38],0.0875357141037528
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21705,119,1.50 [0.92-2.46],0.1051689487105882
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21749,163,1.25 [0.81-1.92],0.3070615677037725
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15199,202,1.55 [1.06-2.28],0.0244317999609978
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20278,185,2.94 [2.29-3.78],3.444155167914335e-17
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2475,101,3.83 [2.61-5.61],6.309113596669788e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2639,307,2.32 [1.77-3.02],6.265575242201984e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20178,85,3.11 [2.30-4.21],2.4053935388284495e-13
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2447,76,14.98 [8.62-26.02],7.772064844323066e-22
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22222,2129,1.46 [1.31-1.64],4.254700130348681e-11
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21943,628,1.41 [1.13-1.75],0.0020122191879952
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20781,450,1.54 [1.19-1.98],0.0009180185248636
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16106,1109,1.74 [1.48-2.04],2.131058803278865e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22935,306,1.65 [1.23-2.22],0.0008652143305926
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21580,272,1.34 [0.96-1.86],0.0848712649440879
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Angina pectoris,19916,1564,1.09 [0.95-1.26],0.2282851237439034
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21684,376,1.11 [0.83-1.48],0.4771710870281602
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21396,88,2.92 [1.86-4.58],3.3015884004204508e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21595,287,1.89 [1.41-2.54],2.525349424244834e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11674,2838,1.30 [1.17-1.45],1.2223511551597969e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,AV-block,17520,675,1.52 [1.25-1.85],2.303854020666917e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22986,579,1.40 [1.12-1.75],0.0030239046369127
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9097,261,2.02 [1.44-2.85],5.710879825702331e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17046,201,1.43 [0.98-2.08],0.0628952168905612
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16952,107,1.61 [0.97-2.65],0.0639831197333111
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23066,79,1.84 [1.05-3.22],0.0332821421015616
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Conduction disorders,18386,1541,1.46 [1.28-1.67],2.5068665140166162e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21074,2747,1.05 [0.95-1.17],0.3296159576070886
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18501,8863,1.12 [1.06-1.19],0.0001846689412825
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21500,336,1.59 [1.20-2.12],0.0013982184707996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Endocarditis,16946,101,1.64 [0.98-2.74],0.0589306343602731
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22779,1653,1.56 [1.37-1.77],9.66730895236229e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertension,19734,7894,1.14 [1.07-1.21],4.753372368616303e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19751,7911,1.14 [1.07-1.22],3.0434054837466382e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22897,93,3.14 [2.18-4.52],6.86865380302747e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12099,259,2.40 [1.77-3.25],1.6519836363186233e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12050,210,4.48 [3.59-5.60],1.1554473793803783e-39
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypotension,22887,1647,1.58 [1.39-1.81],1.3393793584707e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21777,151,0.84 [0.53-1.34],0.4680894153349539
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21250,2898,1.04 [0.94-1.16],0.4142846926229413
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22558,803,1.25 [1.03-1.51],0.0245085597494113
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17362,517,1.43 [1.13-1.80],0.0026341890926237
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22374,1057,1.09 [0.92-1.30],0.3029625461313598
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19262,910,1.19 [0.99-1.43],0.0701148772539456
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22941,185,1.06 [0.71-1.60],0.7627460872600678
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23027,410,1.32 [1.01-1.73],0.0409079162203132
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21228,64,2.91 [1.86-4.53],2.5134703262537646e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other aneurysm,21414,106,1.35 [0.79-2.30],0.2725736571328022
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17438,593,1.61 [1.30-2.00],1.1573592338213344e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21444,136,2.60 [1.78-3.81],9.119910306927692e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21643,335,1.93 [1.47-2.55],2.872176016366597e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17065,220,1.35 [0.94-1.95],0.1076437593431642
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21284,120,1.79 [1.14-2.81],0.0107857270180584
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21210,46,0.85 [0.37-1.95],0.700662714625736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21010,92,1.05 [0.59-1.86],0.8618761749260505
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21341,177,1.25 [0.83-1.87],0.2884605921247928
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18306,1461,1.36 [1.18-1.56],1.561018552062242e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21302,62,3.16 [1.82-5.50],4.6315491926423566e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22037,729,1.97 [1.64-2.37],6.007305897100489e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22301,527,1.67 [1.34-2.09],6.025681933303734e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21899,981,1.40 [1.17-1.66],0.0001530351390202
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9252,416,1.26 [0.95-1.67],0.1032693905227376
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21868,594,2.10 [1.73-2.56],9.392340268189513e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21587,423,1.45 [1.12-1.88],0.0050487789473776
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22375,601,1.00 [0.80-1.26],0.99212829282141
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22970,969,1.40 [1.18-1.66],0.0001405330122924
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17355,510,1.66 [1.33-2.07],7.244050056503347e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22294,520,1.62 [1.29-2.02],3.1661958993488584e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21185,267,2.09 [1.56-2.80],8.307510666957673e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22542,916,1.19 [0.99-1.42],0.0654229320563817
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22527,956,1.22 [1.02-1.46],0.0282676915753232
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21744,63,2.02 [1.08-3.81],0.0288735941065444
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21413,105,1.01 [0.58-1.75],0.979760636199214
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22078,323,1.21 [0.89-1.65],0.2206512822225078
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21649,332,1.19 [0.88-1.60],0.2553194261819255
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Varicose veins,21680,516,1.76 [1.40-2.20],8.442442841314504e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21328,123,1.30 [0.79-2.14],0.2952641723860554
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22796,946,1.16 [0.97-1.38],0.1125313004869415
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22988,334,0.83 [0.61-1.12],0.2253979287392538
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19707,1376,1.14 [0.98-1.33],0.0811139573708499
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Any mental disorder,22535,4204,1.15 [1.05-1.25],0.0018519588138372
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22960,395,0.78 [0.59-1.03],0.0809809942242055
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19782,1451,1.33 [1.15-1.54],9.1719213785457e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18417,86,1.22 [0.67-2.20],0.5155331326290458
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Smoking dependency,22561,1169,1.00 [0.85-1.18],0.9924146861553168
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19775,1444,0.97 [0.84-1.13],0.73626540576111
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Vascular dementia,22170,229,1.77 [1.26-2.49],0.0009709635662185
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23067,592,1.37 [1.09-1.72],0.0064732965628337
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14123,111,1.63 [0.97-2.74],0.0629251894383302
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Bell's palsy,21231,84,1.85 [1.06-3.23],0.0312098265813673
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21641,494,1.09 [0.85-1.40],0.4882957527802066
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral cysts,22615,252,1.32 [0.93-1.87],0.1144764761147564
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22992,412,1.57 [1.22-2.04],0.0005700406652574
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22212,73,1.02 [0.53-1.97],0.9510713356792758
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23050,70,1.31 [0.69-2.49],0.4156144070630916
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22451,88,1.51 [0.85-2.71],0.1627347632132728
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Epilepsy,21564,307,1.64 [1.22-2.22],0.0010881324840774
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22607,1350,1.26 [1.09-1.46],0.0020042424721894
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23014,923,1.19 [0.99-1.43],0.0575820307302148
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22409,3461,1.33 [1.21-1.46],1.8596564541120487e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22686,53,2.54 [1.38-4.66],0.0026492780355945
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hemiplegia,22917,337,1.79 [1.35-2.35],4.010674343173313e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hydrocephalus,22439,76,1.58 [0.85-2.92],0.1457375897113674
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23054,75,1.66 [0.91-3.03],0.1004864449551022
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21212,65,1.00 [0.50-2.01],0.9958433792197684
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21220,73,1.10 [0.58-2.10],0.7662882192786937
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Memory loss,21918,141,1.55 [0.99-2.43],0.0554501811361157
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Migraine,21534,277,1.28 [0.92-1.78],0.1424525861475193
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23021,253,1.23 [0.87-1.74],0.2419789206079561
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Motor neuron disease,14210,175,1.12 [0.73-1.71],0.6066360807410625
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22934,61,0.67 [0.32-1.39],0.286344338773854
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22366,1219,1.21 [1.03-1.42],0.0173865168338387
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Neurological diseases,21588,4353,1.28 [1.18-1.39],7.614792982921497e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22465,326,1.56 [1.16-2.10],0.0033804493322739
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21568,421,1.12 [0.86-1.47],0.3936941669144191
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22992,348,1.88 [1.45-2.44],2.2347986293230844e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17252,978,1.51 [1.27-1.80],4.3976415900175416e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22448,85,1.12 [0.62-2.04],0.7077782976348863
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22523,160,1.62 [1.07-2.47],0.0233142031442122
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22328,237,1.14 [0.79-1.63],0.48434159074644
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21242,95,1.64 [0.96-2.82],0.0724712769695858
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other headache syndromes,21308,51,1.62 [0.78-3.36],0.1964739647982258
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other neurological diseases,22951,588,1.43 [1.14-1.79],0.001697919148411
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other sleep disorders,21773,516,1.13 [0.89-1.44],0.3095580449333577
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23035,685,1.21 [0.98-1.50],0.0716821217771583
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22408,45,1.29 [0.57-2.94],0.5426481520799921
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23068,109,0.95 [0.55-1.62],0.8431936503418838
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Sleep apnoea,22835,437,1.09 [0.84-1.42],0.5122804700578332
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22704,60,1.99 [1.06-3.74],0.0322712292536631
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23056,203,1.24 [0.84-1.82],0.2768796737647384
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21215,68,1.06 [0.54-2.09],0.8601885090373185
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23067,598,1.36 [1.08-1.70],0.0080576734062812
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22109,223,1.79 [1.27-2.52],0.0008884675732809
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22418,153,1.01 [0.64-1.60],0.9516077314139556
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22608,560,1.02 [0.80-1.29],0.8840733811929713
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22814,266,2.99 [2.41-3.73],9.728433211507112e-23
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21835,70,0.77 [0.39-1.52],0.4534945783579267
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21804,39,0.79 [0.32-1.96],0.6114982784268359
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22947,72,2.18 [1.26-3.79],0.0056512956483403
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22752,219,1.00 [0.69-1.47],0.9823624482261843
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2451,77,6.39 [4.43-9.22],3.263939549913661e-23
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3022,116,3.72 [2.58-5.36],1.7243954640457405e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22375,110,1.11 [0.66-1.89],0.6916606373694267
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22770,1421,1.20 [1.03-1.39],0.0157077571083989
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22652,887,1.00 [0.83-1.21],0.9721971913003512
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22071,306,1.17 [0.85-1.60],0.3356462253304747
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22992,944,1.00 [0.83-1.20],0.9683998485840786
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23061,80,0.63 [0.34-1.19],0.1565669872497151
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22917,869,0.95 [0.78-1.14],0.5671578189120161
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23024,491,1.06 [0.83-1.37],0.6349761961160771
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22948,225,1.30 [0.90-1.87],0.1585581735524892
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21866,101,1.35 [0.79-2.30],0.2748521599108398
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21865,100,0.68 [0.39-1.20],0.1858216386054678
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21843,78,0.94 [0.50-1.78],0.8608163043083686
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22935,1006,1.13 [0.95-1.34],0.1834166510176592
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22191,262,1.25 [0.89-1.75],0.1968948623344676
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22117,69,0.61 [0.31-1.19],0.1477145647591647
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22653,120,1.06 [0.64-1.76],0.8126624772815927
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22918,385,0.98 [0.74-1.30],0.8841293439247269
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22267,219,0.84 [0.57-1.23],0.3599532460215854
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22864,141,1.27 [0.80-2.02],0.3085428207522899
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22599,670,1.19 [0.96-1.47],0.1097162148506376
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22424,159,1.32 [0.86-2.04],0.2039322267247177
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20614,3228,1.13 [1.02-1.24],0.0147819689531439
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22872,339,0.89 [0.65-1.20],0.4439751389038074
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23054,190,1.32 [0.89-1.95],0.1698407855901088
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22306,541,1.00 [0.79-1.27],0.9955919521457912
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22621,88,0.88 [0.48-1.60],0.6752378621965145
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23052,71,0.59 [0.30-1.16],0.1253795420339816
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21894,129,0.91 [0.56-1.50],0.7165945557772735
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21940,175,0.95 [0.62-1.45],0.8128525863279522
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21513,164,1.21 [0.79-1.87],0.379389751838239
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22112,64,1.48 [0.76-2.90],0.2481245466459314
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21422,73,0.45 [0.23-0.89],0.0214761392364745
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22042,113,0.86 [0.50-1.46],0.5643211508924928
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22219,290,1.04 [0.75-1.44],0.823802796147189
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21927,162,1.34 [0.87-2.05],0.1827640677707775
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21445,96,1.06 [0.60-1.88],0.8451209464435862
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21478,129,1.20 [0.74-1.96],0.4582657394956018
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20110,2724,1.07 [0.96-1.19],0.227236745551184
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21860,95,1.43 [0.83-2.49],0.1990284371425448
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22770,505,1.20 [0.94-1.53],0.1429109649327551
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22343,78,0.83 [0.44-1.56],0.5538587514195408
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22474,209,1.59 [1.11-2.29],0.0125209726043299
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22847,110,0.85 [0.50-1.46],0.5610876579841774
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23021,140,1.12 [0.70-1.78],0.6327610013595597
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22928,118,1.94 [1.22-3.07],0.004823812222489
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22799,62,1.18 [0.58-2.39],0.6429353698014514
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22806,69,0.92 [0.47-1.82],0.817038041183195
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22960,1239,1.14 [0.98-1.34],0.0920908341518022
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22661,940,1.18 [0.99-1.42],0.0644104339138642
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21873,152,1.23 [0.79-1.91],0.3625283439651804
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21810,89,0.77 [0.43-1.41],0.4020232991227971
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,22876,67,1.45 [0.75-2.80],0.2639297741488297
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22995,186,1.74 [1.20-2.54],0.0037062100644745
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22872,63,2.28 [1.28-4.06],0.0052436774983458
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza,20387,157,2.11 [1.44-3.09],0.0001196736024882
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20384,154,2.06 [1.39-3.04],0.0002840675493404
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14221,103,0.99 [0.56-1.73],0.9589699281928298
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,22961,236,0.98 [0.68-1.42],0.9311927872044956
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15430,1697,1.06 [0.93-1.22],0.3840568940530291
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15792,1674,1.07 [0.93-1.22],0.3648204133649437
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22550,178,1.90 [1.30-2.79],0.0009139685848082
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20335,105,1.80 [1.09-2.98],0.0209143094096016
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bronchiectasis,19358,519,1.57 [1.24-1.99],0.0001708632563256
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18912,73,1.20 [0.63-2.31],0.5818554405633531
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21942,3103,1.16 [1.05-1.29],0.0029457457450485
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21852,72,1.50 [0.79-2.82],0.2120495390640028
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21915,135,1.11 [0.69-1.79],0.6537100496524004
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22782,1625,1.41 [1.23-1.61],1.0766168457702727e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21858,78,1.00 [0.53-1.87],0.9931801244331012
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20922,6089,1.16 [1.08-1.25],3.868924525469837e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22110,330,1.14 [0.84-1.54],0.3987743256351013
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Early onset COPD,21265,108,1.29 [0.77-2.18],0.3334582769791694
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Emphysema,19269,430,1.85 [1.43-2.40],2.959468015870399e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21766,449,1.39 [1.08-1.80],0.0102758864367264
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22812,2582,1.48 [1.33-1.64],3.2555737156079494e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21807,490,1.50 [1.18-1.91],0.0008324648859082
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Later onset COPD,22549,1517,1.42 [1.23-1.64],1.0888062380625826e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23052,498,1.36 [1.06-1.73],0.013851989019788
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Nasal polyp,21877,97,1.65 [0.97-2.81],0.0636475526362765
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22787,1301,1.40 [1.21-1.63],8.051581423674983e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22780,2697,1.27 [1.14-1.41],1.0100236668362904e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22525,745,1.15 [0.94-1.40],0.1892095894059191
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other pleural conditions,20148,65,0.77 [0.38-1.56],0.4682922959343447
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22950,587,1.74 [1.41-2.14],3.143742900377195e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22942,1723,1.33 [1.17-1.51],1.996345749859142e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural effusion,21462,1379,1.38 [1.20-1.60],1.2378750001130122e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural plaque,20333,250,1.12 [0.78-1.59],0.541947911774532
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22524,2294,1.50 [1.34-1.68],6.950095032925979e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22945,391,1.40 [1.06-1.84],0.0162011946963505
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumothorax,20247,164,1.04 [0.67-1.61],0.8669203984131192
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pollen allergy,23057,201,1.01 [0.68-1.50],0.9535280791552398
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22456,93,3.03 [2.04-4.49],3.528903918256383e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14189,71,1.17 [0.60-2.30],0.639751044967203
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22763,1277,1.41 [1.21-1.64],7.178007195040573e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22018,238,1.01 [0.70-1.45],0.9663191951075656
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Viral pneumonia,20532,302,1.75 [1.32-2.33],0.0001110693857028
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22559,242,1.57 [1.13-2.18],0.0070021722255038
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7342,115,1.64 [0.99-2.70],0.0543371554521504
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14596,61,1.87 [0.94-3.73],0.0731020315258541
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute appendicitis,22953,129,0.77 [0.47-1.26],0.2975565851281297
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute gastritis,16046,104,2.03 [1.27-3.24],0.0029977295899012
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21034,198,1.86 [1.31-2.63],0.0005209142891085
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute peritonitis,22576,113,2.13 [1.35-3.36],0.0011131086354192
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22086,62,2.21 [1.20-4.05],0.0108158248480951
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16448,506,1.37 [1.08-1.74],0.0096327517094896
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20980,144,1.38 [0.89-2.15],0.1477333612514862
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22644,144,1.34 [0.86-2.09],0.1953376965497286
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholecystitis,21053,217,1.52 [1.07-2.17],0.0199617696760603
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholelithiasis,21890,1054,1.47 [1.25-1.73],4.2712357185327575e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic gastritis,16290,348,1.45 [1.09-1.93],0.0105190671354659
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20890,54,1.04 [0.49-2.23],0.912942751521923
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22929,125,3.28 [2.40-4.47],8.240426213574343e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Coeliac disease,21331,126,2.03 [1.32-3.14],0.0013419622360403
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Collagenous colitis,21326,102,2.22 [1.41-3.52],0.000637052177942
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22950,159,1.16 [0.75-1.80],0.4915613240307753
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Constipation,22780,2125,1.32 [1.17-1.49],4.332592485783944e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn disease,21312,88,1.87 [1.10-3.21],0.0218044044606039
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22713,67,2.03 [1.12-3.70],0.0202901844563752
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21304,80,2.12 [1.24-3.63],0.0060019306842077
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Dental caries,22452,191,1.32 [0.89-1.95],0.1688855630692024
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19940,2560,1.29 [1.16-1.44],4.255664966973094e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of appendix,22982,158,0.76 [0.48-1.19],0.225184634637134
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of liver,22947,923,1.57 [1.32-1.87],2.7288146470358364e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20515,4573,1.24 [1.14-1.34],3.288612074217977e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22734,473,1.27 [0.99-1.64],0.0585310721810704
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22977,514,1.40 [1.10-1.77],0.0061389605304142
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22354,93,1.35 [0.77-2.37],0.291101665189097
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22227,58,1.52 [0.75-3.06],0.2459038984162883
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22730,1525,1.48 [1.29-1.70],1.7052692795484066e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22244,96,1.70 [1.01-2.88],0.0475790724032319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22355,1519,1.45 [1.26-1.66],1.1652259294020609e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18302,3767,1.07 [0.98-1.17],0.1389201968492422
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16189,247,1.40 [0.99-1.96],0.054413974716552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22974,201,1.15 [0.78-1.69],0.4900689873009562
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23031,27,1.12 [0.38-3.29],0.8303614906725016
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22171,147,2.98 [2.19-4.06],4.768971863423103e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14643,108,1.06 [0.61-1.81],0.8442474484309602
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16497,555,1.04 [0.82-1.32],0.7525915451755054
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastric ulcer,16371,429,1.52 [1.18-1.95],0.0012572652935623
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18591,2649,1.18 [1.06-1.32],0.002024466745889
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16594,652,1.49 [1.21-1.83],0.0001566362777894
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16643,8189,1.18 [1.11-1.26],1.976988102446803e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,GI-bleeding,22476,1271,1.44 [1.24-1.68],1.4731965992770736e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22305,44,0.71 [0.30-1.67],0.4382471117554345
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15527,1182,1.11 [0.94-1.31],0.2159919310740312
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22093,69,2.64 [1.59-4.40],0.0001856447035301
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Hernia,21014,3634,1.19 [1.08-1.30],0.0002428157541161
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impacted teeth,23035,25,1.09 [0.36-3.34],0.8768732158031289
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impaction of intestines,14614,79,2.23 [1.25-3.97],0.0066901462947822
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Inguinal hernia,18467,1087,1.11 [0.94-1.32],0.2098277740198471
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17504,124,0.94 [0.57-1.56],0.8099291656503383
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14648,113,1.33 [0.79-2.25],0.2781996105639218
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21350,145,2.11 [1.42-3.13],0.0002268075151054
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15042,507,1.44 [1.13-1.83],0.0029983996734997
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23038,338,1.19 [0.89-1.60],0.2406595704151405
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22005,781,1.43 [1.18-1.73],0.0002544222456093
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22308,1084,1.43 [1.22-1.69],1.4234342765554732e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16160,218,1.31 [0.90-1.89],0.153073948653006
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophagitis,16632,690,1.19 [0.96-1.46],0.1110140184389806
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23013,134,1.30 [0.81-2.08],0.273937987794165
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17464,84,1.49 [0.83-2.70],0.1840635373849846
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15923,1388,1.17 [1.00-1.36],0.0435542275269371
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21192,356,1.17 [0.87-1.56],0.2993461395269595
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20984,148,1.18 [0.75-1.85],0.4667487169546375
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16465,1930,1.12 [0.98-1.27],0.0866026387104247
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,20749,6214,1.15 [1.07-1.23],0.0001593981640736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22205,209,1.29 [0.89-1.88],0.1824007795181517
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of liver,22789,765,1.54 [1.27-1.87],8.370208988781038e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16703,761,1.39 [1.14-1.69],0.0009708022229433
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21054,218,2.13 [1.55-2.94],3.831150506042791e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22898,435,1.16 [0.89-1.51],0.2676862111698486
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17040,1098,1.52 [1.29-1.78],2.8128401802027125e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22492,1287,1.45 [1.25-1.68],1.2284942836690297e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22440,179,1.56 [1.05-2.32],0.0261498148814881
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16704,2169,1.37 [1.22-1.55],1.6132382453527945e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18102,2160,1.34 [1.19-1.51],7.954158449823607e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22138,114,2.29 [1.51-3.48],0.0001029874061345
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22179,955,1.48 [1.25-1.76],8.590548512199774e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14982,447,1.32 [1.02-1.72],0.0371129150459966
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23027,31,0.96 [0.35-2.65],0.9398211164989888
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15152,617,1.36 [1.09-1.70],0.0072947155454394
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21361,156,1.47 [0.96-2.26],0.0773255976922149
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23055,54,2.42 [1.29-4.53],0.0058335535426569
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22254,102,2.60 [1.69-3.99],1.2651553003997796e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Toxic colitis,21302,78,1.48 [0.81-2.70],0.2012615357522768
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16281,339,1.25 [0.93-1.68],0.1464881181899527
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21393,169,1.42 [0.94-2.15],0.0974889763931397
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21358,134,1.33 [0.83-2.13],0.2280893143827205
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Umbilical hernia,17636,256,1.41 [1.01-1.98],0.0436472353073328
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14779,244,1.55 [1.10-2.20],0.0129038367514055
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ventral hernia,17665,285,1.29 [0.93-1.79],0.1250078236048614
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Volvulus,14629,94,1.19 [0.67-2.12],0.5566729798125285
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22960,424,0.80 [0.61-1.06],0.1144105739899372
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22704,67,2.65 [1.60-4.38],0.0001490505978287
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20508,167,1.67 [1.11-2.51],0.0130846361040013
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22443,835,1.79 [1.51-2.13],3.186939095956255e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21749,141,1.37 [0.87-2.16],0.1773631473194986
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20977,636,1.79 [1.46-2.19],1.7979380580786537e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22727,312,1.39 [1.03-1.89],0.031964339489266
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22969,554,1.35 [1.08-1.70],0.0096007191552415
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22461,46,1.62 [0.76-3.48],0.2122734785365941
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21470,3716,1.29 [1.18-1.41],3.8418203451147696e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22634,436,1.25 [0.96-1.62],0.0940959689647686
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22501,303,1.26 [0.92-1.73],0.1442214881385798
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22681,1073,1.67 [1.43-1.95],1.3546280464242163e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23047,61,1.17 [0.58-2.36],0.6703555352620785
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20399,58,3.27 [1.99-5.38],3.205814289479904e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22260,62,1.59 [0.83-3.06],0.1617315001768903
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22713,298,1.33 [0.97-1.82],0.0723073691113551
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20948,607,1.39 [1.11-1.74],0.0035517264365774
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20428,87,0.71 [0.38-1.31],0.2736766967026319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22981,93,2.19 [1.37-3.52],0.0010898956611951
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21837,229,1.76 [1.27-2.46],0.0008042174121164
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22860,223,0.87 [0.60-1.26],0.457098479077719
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22512,97,1.08 [0.62-1.88],0.7920688968784471
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20420,79,0.84 [0.44-1.58],0.5859573152597687
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22457,2116,1.45 [1.29-1.63],5.244121956846779e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20993,652,1.50 [1.21-1.85],0.0001778071325511
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20432,91,0.73 [0.40-1.34],0.3120352506989443
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22975,338,1.03 [0.76-1.39],0.858540258362355
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22491,76,2.39 [1.41-4.03],0.0011468306796099
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22912,275,1.02 [0.73-1.43],0.90254032281313
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22993,457,0.86 [0.66-1.12],0.2617667972766845
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20465,124,1.74 [1.09-2.76],0.0199679008640027
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20682,341,0.94 [0.69-1.27],0.6701559853292317
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22981,445,0.85 [0.65-1.12],0.2505911909909709
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20680,339,2.25 [1.77-2.87],4.525834867495491e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23039,151,1.71 [1.13-2.60],0.0116966778125616
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19232,82,1.35 [0.75-2.44],0.3147294592879875
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20321,6430,1.13 [1.05-1.21],0.0005799362243638
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18901,5010,1.13 [1.04-1.22],0.0032708986287553
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19203,53,1.50 [0.73-3.10],0.2712351372637047
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19134,145,1.58 [1.02-2.45],0.0427498184108968
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19179,190,1.65 [1.13-2.41],0.0100476977476322
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22801,64,1.31 [0.66-2.57],0.43834252450136
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19137,148,1.88 [1.23-2.88],0.0034724974882714
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15375,1484,0.95 [0.82-1.10],0.515094811235739
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22857,247,1.07 [0.75-1.52],0.7259071825539791
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19575,586,1.16 [0.92-1.45],0.2177004037030438
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18672,8017,1.11 [1.04-1.18],0.0012550511223155
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20529,119,1.09 [0.65-1.81],0.746517245657513
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19332,182,1.40 [0.94-2.09],0.0986591441723432
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19655,505,1.06 [0.83-1.36],0.6515017480386914
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22133,3144,1.17 [1.06-1.29],0.0014651756724393
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19456,306,0.98 [0.71-1.36],0.9127505253131404
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19297,147,1.28 [0.81-2.01],0.2844076590838318
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19263,113,0.95 [0.56-1.62],0.8579257065257987
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22314,102,0.90 [0.51-1.58],0.7225644216405669
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15897,2006,1.16 [1.03-1.32],0.0168283583741975
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14687,796,1.64 [1.36-1.98],2.0948104545893134e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22973,789,1.48 [1.24-1.78],2.354791730511673e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13968,77,0.35 [0.18-0.68],0.0016927140314219
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14193,302,1.36 [1.00-1.86],0.0497167223610881
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19417,267,0.90 [0.64-1.27],0.5425681223689696
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14375,484,1.09 [0.84-1.40],0.5219736973516802
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19069,80,1.90 [1.07-3.37],0.0276400898975314
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19671,682,1.26 [1.02-1.55],0.0314894222909234
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19303,314,1.10 [0.81-1.51],0.545606877835946
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14346,455,1.07 [0.83-1.40],0.5989626840405382
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19223,73,0.81 [0.42-1.57],0.5399998068961444
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19210,60,0.93 [0.45-1.91],0.8393885202778335
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20495,85,2.78 [1.85-4.16],7.836084942506599e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22640,2230,1.29 [1.15-1.45],1.9677354013558924e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21970,1560,1.32 [1.15-1.51],0.0001079524543368
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22894,542,1.58 [1.26-1.99],7.299839105407052e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17015,3124,1.26 [1.14-1.38],5.873799311852837e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13933,42,0.64 [0.26-1.54],0.3196314376128074
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19255,105,1.21 [0.71-2.06],0.4897846794030612
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13962,71,1.51 [0.80-2.85],0.2069436772821397
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14028,137,1.60 [1.02-2.49],0.0395855711245429
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20657,247,1.07 [0.75-1.52],0.7065019159961063
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20920,510,1.35 [1.06-1.72],0.0142389609226059
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23045,113,1.47 [0.89-2.44],0.1318490144414769
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20972,1983,1.25 [1.10-1.41],0.0004376619288026
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19226,76,2.19 [1.29-3.74],0.0039043798393904
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14044,153,1.70 [1.13-2.57],0.0106883968785303
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19780,791,1.14 [0.94-1.39],0.1830992075629837
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16079,2188,1.19 [1.05-1.33],0.0047615858870108
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22340,128,1.28 [0.79-2.09],0.320137590151091
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23057,64,3.01 [1.89-4.79],3.759168219148252e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19228,78,0.92 [0.49-1.74],0.8082385235428327
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20500,1350,1.40 [1.21-1.62],7.511604327396918e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19259,109,0.97 [0.57-1.67],0.9177510985941576
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15966,2075,1.18 [1.05-1.33],0.0074338803286548
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20529,119,0.65 [0.38-1.09],0.1006882140452469
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19188,38,1.19 [0.48-2.95],0.7098805292688397
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19185,196,0.81 [0.54-1.21],0.3108818861479341
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19835,685,1.40 [1.15-1.72],0.0011189927682338
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22700,488,1.26 [0.98-1.61],0.0741006249851772
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19655,666,1.27 [1.03-1.57],0.0262823571894972
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22909,537,1.58 [1.26-1.98],8.424828255845719e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23041,68,1.76 [0.95-3.27],0.0737908214091936
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19315,165,1.01 [0.65-1.57],0.958123885818054
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17953,891,1.38 [1.15-1.65],0.0004632698880843
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19793,643,1.53 [1.24-1.88],6.64897637343505e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19424,274,0.86 [0.61-1.21],0.3713486367809965
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13959,68,1.93 [1.08-3.45],0.0257713596258178
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17016,3125,1.27 [1.15-1.40],1.8694193701795096e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14725,834,1.56 [1.30-1.87],1.51093678558638e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22587,375,0.97 [0.73-1.30],0.8583361683573408
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23013,81,2.19 [1.29-3.72],0.0037581784731302
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20409,71,1.64 [0.87-3.09],0.1225802888387649
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13956,65,3.08 [1.98-4.78],5.78320605768355e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19098,109,1.18 [0.70-2.01],0.5340898943525743
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14440,549,1.63 [1.30-2.04],1.7000244746057866e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19484,334,1.10 [0.81-1.50],0.5262829291163335
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19273,284,1.39 [1.01-1.92],0.0424145431203549
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19255,266,1.37 [0.98-1.92],0.0628984217960533
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16205,66,2.08 [1.16-3.74],0.0145250032419521
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23047,74,1.81 [1.00-3.25],0.0486109973797319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19705,555,1.12 [0.89-1.42],0.3419363789835449
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22303,91,2.59 [1.67-4.02],2.352039044383064e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21786,2636,1.28 [1.15-1.42],6.57704385475212e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19297,147,1.15 [0.73-1.82],0.5504678031778055
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19701,712,1.33 [1.08-1.63],0.0063475828283147
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21691,274,0.79 [0.57-1.12],0.1852513935210645
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19247,258,0.88 [0.62-1.25],0.4630549227012834
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20991,2002,1.23 [1.08-1.39],0.0011740757475108
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20298,1309,1.33 [1.14-1.54],0.0002469489573294
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19212,62,1.23 [0.61-2.46],0.5635388965464793
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22333,121,3.10 [2.21-4.36],5.375063798435832e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19313,163,1.35 [0.88-2.06],0.1700053852502019
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19240,90,1.09 [0.60-1.96],0.7773249759906132
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13967,76,1.88 [1.06-3.33],0.0305410340494431
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21556,2253,2.18 [1.95-2.43],2.2429722519139875e-44
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9247,25,0.66 [0.34-1.29],0.228750392328029
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11717,33,0.91 [0.34-2.46],0.8530968790956319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22740,308,1.03 [0.75-1.41],0.8533867238120716
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22538,106,0.74 [0.43-1.28],0.2766749819808382
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21634,2331,2.71 [2.47-2.98],3.096537064740693e-96
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22832,132,4.00 [3.13-5.12],2.74831963058548e-28
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22759,410,1.36 [1.05-1.77],0.0219572193574497
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cystitis,19211,299,1.56 [1.15-2.12],0.0045561303912842
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Dialysis,19399,96,5.94 [4.52-7.81],2.120658088736111e-37
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10159,2141,1.12 [0.99-1.27],0.0606328713549669
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11820,136,1.00 [0.62-1.62],0.9929019153745264
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9261,39,0.63 [0.25-1.57],0.322848265669781
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9803,581,0.99 [0.78-1.25],0.9237976228626772
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19003,6284,1.39 [1.30-1.49],2.0789758856470558e-20
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22798,98,4.33 [3.35-5.59],3.5295007409440287e-29
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8136,118,0.89 [0.53-1.49],0.653037119108808
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19375,350,1.51 [1.12-2.03],0.0061649204120242
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9840,1822,1.15 [1.01-1.31],0.0363026042348131
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11885,157,0.86 [0.55-1.34],0.4976246891678583
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8145,127,0.75 [0.45-1.24],0.264394521473114
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19000,88,1.74 [1.00-3.01],0.0488946755873593
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10253,1031,1.07 [0.90-1.27],0.4513987296664229
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8078,60,0.63 [0.30-1.32],0.2201386031320899
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9261,39,1.44 [0.61-3.39],0.4031054647809809
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23053,90,1.45 [0.83-2.55],0.1941360673988221
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23056,84,1.78 [1.02-3.12],0.0428775189477574
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21874,2962,1.39 [1.26-1.53],9.670075044224391e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19858,946,1.31 [1.10-1.57],0.0024136110279536
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11736,52,0.92 [0.42-2.00],0.8300446728446753
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22983,634,1.62 [1.32-2.00],3.928489448180566e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8170,152,1.53 [0.97-2.40],0.064534747102373
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8178,160,1.43 [0.92-2.22],0.112203197472806
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8169,151,0.92 [0.58-1.45],0.7091118621593012
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23026,85,1.51 [0.85-2.70],0.161893499032916
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21274,2362,1.43 [1.28-1.59],2.5407691962494416e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11810,82,0.77 [0.41-1.45],0.4221445463527054
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9289,67,1.05 [0.53-2.09],0.8786944641379988
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9361,139,1.11 [0.69-1.78],0.6643461021615501
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9273,51,1.17 [0.54-2.54],0.682848681187692
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9321,99,0.78 [0.44-1.39],0.4058168452257072
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19438,413,1.60 [1.22-2.09],0.0006043661870569
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22551,202,1.79 [1.25-2.56],0.0015388510120049
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9347,125,0.97 [0.58-1.60],0.8964179592422531
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9247,25,1.11 [0.36-3.39],0.8587592577523736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9432,210,0.93 [0.63-1.36],0.7002838975536503
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9314,92,1.02 [0.57-1.84],0.9398602217500664
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9427,205,1.11 [0.75-1.63],0.6061164740390224
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22748,48,2.39 [1.24-4.61],0.0096380174518621
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8174,156,1.21 [0.77-1.90],0.4109983568027454
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22776,3751,2.07 [1.90-2.25],1.0451615633640726e-64
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19122,97,2.88 [1.89-4.37],7.168647937096403e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19484,181,3.55 [2.59-4.85],2.087399380255552e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22470,38,1.36 [0.58-3.21],0.481062597427772
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19185,273,1.32 [0.95-1.83],0.1016068803930876
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22826,394,0.95 [0.72-1.26],0.7259926932978048
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9258,36,0.43 [0.17-1.10],0.0788652257195396
